Gene: DRD4
Official Full Name: dopamine receptor D4provided by HGNC
Gene Summary: This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats; the sequence shown contains four repeats. [provided by RefSeq, Jul 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA16178 | DRD4 Knockout cell line (AC16) | Human | DRD4 | 1:3-1:4 | negative | Online Inquiry |
| KOA31625 | DRD4 Knockout cell line (BEAS-2B) | Human | DRD4 | 1:3~1:4 | negative | Online Inquiry |
| KOA47042 | DRD4 Knockout cell line (U-2932) | Human | DRD4 | 1:2-1:4 | negative | Online Inquiry |
| KOA62439 | DRD4 Knockout cell line (TPC-1) | Human | DRD4 | 1:5-1:8 | negative | Online Inquiry |
| KOA77864 | DRD4 Knockout cell line (NCM460) | Human | DRD4 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.